First human tests for Plant-Based injection complete
NCT ID NCT07457008
Summary
This early-stage study aimed to check the safety and see how the body processes a new injection made from a plant compound called Ginkgolide B. It involved 36 healthy Chinese adults who received either the injection or a placebo. The main goal was to monitor for side effects and measure how long the compound stays in the bloodstream after single and multiple doses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West China Second University Hospital
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.